The unique transcriptional response produced by concurrent estrogen and progesterone treatment in breast cancer cells results in upregulation of growth factor pathways and switching from a Luminal A to a Basal-like subtype
- Eleanor F. Need
- , Luke A. Selth
- , Andrew P. Trotta
- , Damien A. Leach
- , Lauren Giorgio
- , Melissa A. O'Loughlin
- , Eric Smith
- , Peter G. Gill
- , Wendy V. Ingman
- , J. Dinny Graham
- , Grant Buchanan
Research output: Contribution to journal › Article › peer-review
32
Citations
(Scopus)
39
Downloads
(Pure)